CISATRACURIUM MYLAN cisatracurium (as besilate) 10 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium mylan cisatracurium (as besilate) 10 mg/5 ml solution for injection vial

medtas pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium mylan injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium Kabi 2 mgml solution for injection or infusion Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cisatracurium kabi 2 mgml solution for injection or infusion

fresenius kabi malaysia sdn. bhd - cisatracurium besylate -

Atracurium besilate 25mg/2.5ml solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atracurium besilate 25mg/2.5ml solution for injection ampoules

actavis uk ltd - atracurium besilate - solution for injection - 10mg/1ml

Atracurium besilate 250mg/25ml solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atracurium besilate 250mg/25ml solution for injection ampoules

actavis uk ltd - atracurium besilate - solution for injection - 10mg/1ml

Atacure Injection (2.5 mL) 25 mg/2.5 ml Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

atacure injection (2.5 ml) 25 mg/2.5 ml

شركة أدوية الحكمة - hikma pharmaceuticals - atracurium besylate 25 mg/2.5 ml - 25 mg/2.5 ml

Cisatracurium-hameln 2 mgml solution for injectioninfusion Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cisatracurium-hameln 2 mgml solution for injectioninfusion

imeks pharma sdn. bhd. - cisatracurium besylate -

TRACRIUM atracurium besilate 25mg/2.5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

tracrium atracurium besilate 25mg/2.5ml injection ampoule

aspen pharmacare australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; benzenesulfonic acid - tracrium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

ATRACURIUM BESILATE 10 Micromol Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

atracurium besilate 10 micromol solution for injection

hospira uk ltd - atracurium besilate - solution for injection - 10 micromol

ATRACURIUM BESILATE, VIAL 10 Micromol Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

atracurium besilate, vial 10 micromol solution for injection

hospira uk ltd - atracurium besilate - solution for injection - 10 micromol

Nimbex 2mg/ml solution for injection Malta - English - Medicines Authority

nimbex 2mg/ml solution for injection

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cisatracurium - solution for injection - cisatracurium 2 mg/ml - muscle relaxants